Clinical trials
Hypoparathyroidism trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 3 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Recruiting | 8 |
| Active, not recruiting | 4 |
| Terminated | 4 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shire | 10 |
| Ascendis Pharma A/S | 3 |
| Calcilytix Therapeutics, Inc., a BridgeBio company | 3 |
| MBX Biosciences | 3 |
| National Institute of Dental and Craniofacial Research (NIDCR) | 3 |
| Sumitomo Pharma Switzerland GmbH | 3 |
| Ascendis Pharma Bone Diseases A/S | 2 |
| Columbia University | 2 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Bettina Mittendorfer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypoparathyroidism | 43 |
| Hypocalcemia | 9 |
| Endocrine System Diseases | 5 |
| Parathyroid Diseases | 5 |
| DiGeorge Syndrome | 4 |
| Hypercalciuria | 4 |
| Bone Diseases, Metabolic | 3 |
| Osteoporosis | 3 |
| Thyroid Diseases | 3 |
| Calcium Metabolism Disorders | 2 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.